Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab

Published:2023-01-01 Issue:1 Volume:62 Page:91-94
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Horino Taro¹,Eguchi Tomohiro¹,Inotani Satoshi¹,Hirose Akira²,Ishihara Masayuki³,Yagyu Kenichi⁴,Uchida Kazushige²,Fujieda Mikiya³,Terada Yoshio¹

Affiliation:

1. Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Japan

2. Department of Gastroenterology and Hepatology, Kochi Medical School, Japan

3. Department of Paediatrics, Kochi Medical School, Japan

4. Science Research Center, Kochi Medical School, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/1/62_9425-22/_pdf

Reference5 articles.

1. 1. Herbst RS, Bajorin DF, Bleiberg H, et al. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology. J Clin Oncol 24: 190-205, 2006.

2. 2. Eremina V, Cui S, Gerber H, et al. Vascular endothelial growth factor A signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17: 724-735, 2006.

3. 3. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136, 2008.

4. 4. Cortazar FB, Marrone KA, Troxell ML, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int 90: 638-647, 2016.

5. 5. Kitchlu A, Jhaveri KD, Wadhwani S, et al. A systematic review of immune checkpoint inhibitor-associated glomerular disease. Kidney Int Rep 6: 66-77, 2020.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of biopsy‐proven acute interstitial nephritis following atezolizumab‐bevacizumab treatment of advanced unresectable hepatocellular carcinoma;Cancer Reports;2024-07

2. Systemic therapies in hepatocellular carcinoma: A revolution?;United European Gastroenterology Journal;2024-01-24

3. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy;Journal of Clinical Pathology;2024-01-19

4. Cadonilimab for Gastric Adenocarcinoma Complicated by Pulmonary Tumor Thrombotic Microangiopathy: A Case Report and Literature Review;Advances in Clinical Medicine;2024

5. Atezolizumab/bevacizumab;Reactions Weekly;2023-02-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3